Incanthera plc is a United Kingdom-based dermatology and oncology therapeutics company focused on the discovery and development of targeted solutions. The Company provides analytical services to evaluate the safety, efficacy, and performance of skincare and dermatological products. Skin + CELL is the Company’s luxury skincare brand, utilizing advanced formulation and delivery expertise, to bring scientifically proven formulations to cosmetics. Skin + CELL’s range of products are based on clinically designed formulations, enriched with targeted bioactive B3 (an activated form of niacinamide) that are delivered directly into the skin's cells to optimize and protect cellular health, energy and protective capabilities. Skin + CELL's luxury skincare range extends across face, body, hand, face serum and eye serum.
Company Information
About this company
Key people
Timothy Mccarthy
Executive Chairman
Simon J. Ward
Chief Executive Officer, Director
Laura Brogden
Chief Financial Officer
Suzanne Brocks
Head of Communications and Company Secretary
John Michael George Howes
Non-Executive Independent Director
Caroline Murray
Senior Independent Non-executive Director
Click to see more
Key facts
- Shares in issue137.94m
- EPICINC
- ISINGB00BGL7YW15
- LocationUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap£4.14m
- Employees8
- ExchangeAquis Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.